These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31597437)

  • 1. Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases".
    Turan Y
    Angiology; 2020 Jan; 71(1):88. PubMed ID: 31597437
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?".
    Turan Y; Demir V; Turan E; Hidayet Ş
    Angiology; 2020 Jan; 71(1):85-86. PubMed ID: 31450946
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.
    Kim M; Jun DW
    Clin Nutr; 2020 Jan; 39(1):306. PubMed ID: 31812470
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".
    Kutlu O; Altun Ö; Dikker O; Aktaş Ş; Özsoy N; Arman Y; Özgün Çil E; Özcan M; Aydın Yoldemir Ş; Akarsu M; Toprak İD; Kırna K; Kutlu Y; Toprak Z; Eruzun H; Tükek T
    Med Princ Pract; 2020; 29(1):98. PubMed ID: 31505512
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Jun DW; Lee S
    Clin Nutr; 2018 Jun; 37(3):1090. PubMed ID: 29478888
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Lee SM; Jun DW
    Clin Nutr; 2018 Apr; 37(2):759. PubMed ID: 29366517
    [No Abstract]   [Full Text] [Related]  

  • 7. Author response to Letter to the Editor: "Statins and non-alcoholic fatty liver disease".
    van den Berg EH; de Meijer VE; Blokzijl H
    Liver Int; 2019 Sep; 39(9):1788-1789. PubMed ID: 31310401
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(3):141-148. PubMed ID: 27692633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H
    Can J Cardiol; 2013 Sep; 29(9):1139.e9. PubMed ID: 23352427
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply.
    Mullish BH; Forlano R; Abeles RD; Thursz MR; Manousou P
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1140-1141. PubMed ID: 31657474
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
    Carrieri P; Duracinsky M; Marcellin F; Lazarus JV
    Hepatology; 2019 Jul; 70(1):443-444. PubMed ID: 30472796
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández-Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(4):185-200. PubMed ID: 27692632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    McHenry S; Ciorba MA; Deepak P
    Inflamm Bowel Dis; 2020 May; 26(6):e46. PubMed ID: 32130410
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Lan Y; Wang L
    Clin Nutr; 2021 Nov; 40(11):5445-5446. PubMed ID: 34653824
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance?
    Aldamiz-Echevarria L; Villate O
    Clin Nutr; 2019 Aug; 38(4):1962. PubMed ID: 31104878
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].
    Xing A; Ji C; Shi J; Du X; Huang Z; Lin L; Xiong H; Wu S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jan; 36(1):40-4. PubMed ID: 25876863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease-time for action! Authors' reply.
    Zhang X; Wong GL; Wong VW; Yip TC
    Aliment Pharmacol Ther; 2023 May; 57(10):1172-1173. PubMed ID: 37094323
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.
    Kobori M; Takahashi Y; Sakurai M; Ni Y; Chen G; Nagashimada M; Kaneko S; Ota T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 May; 14(5):726. PubMed ID: 29576483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.